Eton Pharmaceuticals, Inc. (ETON)

Last Closing Price: 22.97 (2026-04-23)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Eton Pharmaceuticals, Inc. (ETON) had Net Income of $1.48M for the most recently reported fiscal quarter, ending 2025-12-31.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
$21.28M
Net Income
$1.48M
$8.18M
$13.10M
$18.82M
$2.46M
$-1.05M
$1.41M
$1.41M
$1.48M
$1.48M
$1.48M
$1.48M
$2.46M
$3.66M
26.91M
26.91M
$0.06
$0.06
Balance Sheet Financials
$60.58M
$0.33M
$31.53M
$92.11M
$38.49M
$21.77M
$27.47M
$65.96M
$26.15M
$-4.72M
$26.15M
27.05M
Cash Flow Statement Financials
$10.52M
$-0.33M
$0.81M
$14.94M
$25.94M
$11.01M
$5.51M
--
--
Fundamental Metrics & Ratios
1.57
--
--
0.45
1.17
61.56%
11.58%
11.58%
--
6.64%
6.97%
$10.19M
--
--
--
0.23
0.53
1.81
49.72
5.67%
-31.39%
1.61%
3.09%
$0.97
$0.38
$0.39